Year in review: Alzheimer’s drug may clarify disease’s origins | Science News

ADVERTISEMENT

REAL SCIENCE. REAL NEWS.

Help us keep you informed.

Support Science News.


Feature

Year in review: Alzheimer’s drug may clarify disease’s origins

Treatment shows early promise in sweeping away amyloid brain plaques

By
7:35am, December 14, 2016
amyloid-beta

PLAQUE BUSTER A new Alzheimer’s drug shows early promise in clearing amyloid-beta plaques (illustrated) from the brain.

A quarter century after scientists proposed an idea that profoundly influenced the arc of Alzheimer’s research, they might finally find out whether they are correct. A new antibody drug called aducanumab appears to sweep the brain clean of sticky amyloid-beta protein. The drug may or may not become a breakthrough Alzheimer’s treatment — it’s too soon to say — but either way it will probably answer a key question: Have researchers been aiming at the right target?

According to the proposal, called the amyloid hypothesis, Alzheimer’s disease, estimated to affect more than 5 million people in the United States alone, is caused by abnormal buildup of A-beta protein in the brain. The buildup chokes vital brain areas and destroys nerve cells. Despite

This article is only available to Science News subscribers. Already a subscriber? Log in now. Or subscribe today for full access.

Get Science News headlines by e-mail.

More on 2016 Top 10

From the Nature Index Paid Content